[Pregnancy in paroxysmal nocturnal hemoglobinuria: from survival to life].
M A VinogradovaAlexander Dmitrievich KulaginRoman G ShmakovPublished in: Terapevticheskii arkhiv (2022)
Thus, eculizumab allows not only to increase the survival rate of patients with PNH, but also to comprehensively improve their quality of life, including the possibility of safe childbirth.